MF Gyan
sectorHigh risk2 year old

PGIM India Healthcare Fund - Direct Plan - Direct IDCW

Invests only in one industry or theme (like banking, pharma, tech). Highly concentrated — bigger swings. From PGIM India Mutual Fund. It's been running since 11 Dec 2024.

This fund is under 3 years old — its short track record makes comparing to peers or judging consistency less reliable.
Latest price per unit
₹12.47
▼ 0.80% today
As of 4 Sep 2026 · updated once each business day

What ₹1 lakh would have become

Based on past returns
Invested 1 year ago
₹1.25 L
▲ ₹24.7k gain · 24.7% / year

These are calculations from the fund's past prices, not a prediction. Real future returns can and often do differ.

SIP simulator

Play with a monthly investment

Slide the amount and switch the duration. Left column uses real past prices. Right column projects forward using this fund's historical rate — a calculation, not a prediction.

₹5.0k
Looking back · real
You would have invested₹60.0k
Value today₹70.8k
Gain / loss+₹10.8k
XIRR (annualised)41.28%
Looking forward · hypothetical
You would invest₹60.0k
Would become*₹75.3k
Projected gain*+₹15.3k
*at this fund's historical rate of 41.28% per year. Actual future returns can be different — sometimes very different.
Value Cumulative invested
Reality check. The backward SIP is real math on real past NAVs. The forward projection assumes the fund keeps up its historical rate — which rarely happens exactly. Past performance is not a promise. MF Gyan does not recommend any specific investment.
How it compares to peers

Vs 109 other funds in Equity Schemes - Thematic Fund

Same plan
1-year return
24.72%median 5.50% (+19.22%)
Rank #8 of 110Beats 92% of peers
Bumpiness (3Y)
13.16%median 15.81% (-2.65%)
Rank #9 of 110Less risky than 91% of peers
Worst-ever drop
-14.45%median -22.78% (+8.33%)
Rank #93 of 110Less risky than 15% of peers

Descriptive rankings within the same category and plan. Not a recommendation — one fund beating another historically does not mean it will continue to do so.

Year by year

Calendar-year returns. 2 of last 3 years were positive.

+1%
2024
-1%
2025
+25%
2026
Best year
2026 · 24.70%
Worst year
2025 · -1.47%

Price over time

How the per-unit price has moved. Tap a range to zoom in.

Bumpiness & worst drops

Day-to-day bumpiness
13.2%

The value swings roughly 13% up or down in a typical year. Finance-speak calls this volatility.

Worst drop ever
-14.45%

A lump sum invested at the previous peak would have temporarily lost about this much before recovering. Finance-speak calls this max drawdown.

Similar funds you might want to look at

Same category, same plan, sorted by 3-year return. Not recommendations — just neighbours.

Head-to-head comparisons

Side-by-side comparisons of PGIM India Healthcare Fund - Direct Plan - Direct IDCW against other sector funds.

Technical details (for the pros)
CAGR — 1 year24.72%
CAGR — 3 years—
CAGR — 5 years—
CAGR — since launch13.74%
Volatility — 1 year (annualised)12.28%
Volatility — 3 years (annualised)13.16%
Max drawdown — 1 year-8.54%
Max drawdown — 3 years-14.45%
Sharpe ratio — 1 year (rf=6%)1.35
Sharpe ratio — 3 years (rf=6%)0.54

Fund info

Fund house
PGIM India Mutual Fund
Category
Equity Schemes - Thematic Fund
Plan
Direct
Option
IDCW
ISIN (Growth)
INF663L01Z60
ISIN (Div re-invest)
INF663L01Z78
Fund code
153037
First price on record
11 Dec 2024 · 429 daily prices

About PGIM India Healthcare Fund - Direct Plan - Direct IDCW

PGIM India Healthcare Fund - Direct Plan - Direct IDCW is a Equity Schemes - Thematic Fund offered by PGIM India Mutual Fund under the Direct plan with the IDCW option. It has approximately 2 year of NAV track record. The fund falls in the sector category — Invests only in one industry or theme (like banking, pharma, tech). Highly concentrated — bigger swings.

The current NAV of PGIM India Healthcare Fund - Direct Plan - Direct IDCW is ₹12.4700 (as of 4 Sep 2026). Historically, it has delivered 24.70% over the last year. Returns are historical and don't predict future performance.

Over the last three years, the fund's prices have moved with 13.2% annualised volatility — a "high" level of bumpiness; its deepest peak-to-trough fall on record was 14.5%. Being mentally prepared for drawdowns of this size is what separates long-term investors from reactive traders.

Frequently asked

What is the latest NAV of PGIM India Healthcare Fund - Direct Plan - Direct IDCW?+

The latest NAV of PGIM India Healthcare Fund - Direct Plan - Direct IDCW is ₹12.4700 as of 4 Sep 2026, down 0.80% from the previous day. NAV is updated once a business day after the market close.

What are the returns of PGIM India Healthcare Fund - Direct Plan - Direct IDCW?+

PGIM India Healthcare Fund - Direct Plan - Direct IDCW has delivered 1-year return 24.70%, since-inception CAGR 13.74%. Returns are historical and don't predict future performance — markets move in cycles.

What category does PGIM India Healthcare Fund - Direct Plan - Direct IDCW belong to?+

PGIM India Healthcare Fund - Direct Plan - Direct IDCW is categorised as Equity Schemes - Thematic Fund. Invests only in one industry or theme (like banking, pharma, tech). Highly concentrated — bigger swings.

How risky is PGIM India Healthcare Fund - Direct Plan - Direct IDCW?+

Based on its 3-year annualised volatility of 13.2%, PGIM India Healthcare Fund - Direct Plan - Direct IDCW sits in the "high" risk bucket. Volatility measures how much prices swing — higher means bigger ups and downs along the way.

Is PGIM India Healthcare Fund - Direct Plan - Direct IDCW a direct plan?+

PGIM India Healthcare Fund - Direct Plan - Direct IDCW is a Direct plan (no distributor commission — lower expense ratio) with the IDCW option (periodic distributions, taxable at your slab rate).

How old is PGIM India Healthcare Fund - Direct Plan - Direct IDCW?+

PGIM India Healthcare Fund - Direct Plan - Direct IDCW has NAV history available from 11 Dec 2024 — approximately 2 year of track record and 429 daily NAV observations.

Numbers are computed from stored daily prices from mfapi.in/AMFI. This is descriptive analytics, not investment advice. Past performance is not indicative of future returns.